gplx/scripts/templates/TestPage_MDR.wiki

50 lines
2.2 KiB
Plaintext
Raw Permalink Blame History

This file contains ambiguous Unicode characters

This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.

{{RegDocument
| area_of_validity = EU
| scope = MD
| document_type = Regulation
| name = Medical Device Regulation (EU) 2017/745
| version = 2017/745, amended by 2023/607
| source = https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745
| language = EN, DE, FR (all EU official languages)
| status = Current
| restricted_access = No
}}
The Medical Device Regulation (MDR) 2017/745 replaces the former Medical Device Directive (MDD 93/42/EEC) and the Active Implantable Medical Device Directive (AIMDD 90/385/EEC). It establishes a uniform regulatory framework for medical devices across EU member states, with a strong focus on clinical evidence, post-market surveillance, and traceability.
Full application started on 26 May 2021. The amendment 2023/607 introduced a phased transition period for legacy devices.
== Key references ==
{| class="wikitable" style="width:100%;"
! Topic / Keyword(s) !! Category / Chapter !! Scope !! Linked document !! Description
{{Reference
| topic = Post-market surveillance, PMCF
| category = Clinical
| scope = MD
| linked_document = [[MDR 2017/745 Articles 8386 & Annex XIV Part B: Post-Market Surveillance and PMCF]]
| description = Articles 8386 define the mandatory PMS system; Annex XIV Part B specifies PMCF requirements.
}}
{{Reference
| topic = Unique Device Identification, UDI, Traceability
| category = Labelling
| scope = MD
| linked_document = [[MDR 2017/745 Articles 2729 & Annex VI: Unique Device Identification (UDI)]]
| description = Articles 2729 and Annex VI establish the UDI system. All devices must carry a UDI carrier on label and packaging.
}}
{{Reference
| topic = Clinical evaluation, Clinical evidence
| category = Clinical
| scope = MD
| linked_document =
| description = Article 61 and Annex XIV Part A define the clinical evaluation process and documentation requirements (CER). ''Page not yet created.''
}}
|}
== Related documents ==
* [[In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746]] Parallel regulation for IVDs
[[Category:Medical Devices]]
[[Category:EU Regulation]]